Search
for
Sort by
Research 91–120 of 1000+
- New insights into the role of Runx1 in epithelial stem cell biology and pathology
- Protective Effects of Melatonin on the Skin: Future Perspectives
- Zinc and Zinc Transporters in Dermatology
- Photobiomodulation in Dermatology: Harnessing Light from Visible to Near Infrared
- Present and Future Use of Exosomes in Dermatology
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- News updates
- Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen
- Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- A new look at an old option in the treatment of early-stage prostate cancer: hormone therapy as an alternative to watchful waiting
- Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Table_2.docx
- Table_1.docx
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study
- Tebentafusp-tebn (Kimmtra®)
- The exploration of mitochondrial‐related features helps to reveal the prognosis and immunotherapy methods of colorectal cancer
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- The role of PEDF in ageing and development: reduction of oxidative damage and support for stem cells
- Folliculotropic Mycosis Fungoides: Update on Diagnosis, Clinicopathological Stage, and Management
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- The Who’s, What’s, and “Y”s: Y Sex Chromosome Loss and Methylation for Analysis in Male Aging and Mortality and Forensic Science Applications
- Induction plus adjuvant chemotherapy, combined treatment with nimotuzumab, and intensity-modulated radiation therapy for N3 stage nasopharyngeal carcinoma